Stock APLM APOLLOMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Apollomics, Inc.

Equities

APLM

KYG0411D1079

Delayed Nasdaq
Other stock markets
 15:14:46 20/06/2024 BST 		5-day change 1st Jan Change
0.1951 USD -5.06% Intraday chart for Apollomics, Inc. -5.11% -79.78%
06-04 Apollomics Announces Vebreltinib Data At the 2024 American Society of Clinical Oncology Annual Meeting CI
05-08 Apollomics, Inc. Appoints Robert Lin to the Board of Directors CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
APOLLOMICS, INC. Stock Apollomics, Inc.
 22.55M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 112B
ARGENX SE Stock argenx SE
 22.57B -
BIONTECH SE Stock BioNTech SE
 20.82B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 16.3B -
  1. Stock Market
  2. Equities
  3. APLM Stock
  4. Charts Apollomics, Inc.
  5. Sector Chart